Symbiopathic
🔷 Notice on U.S. Trade Compliance and Classification (Effective 1 August 2025)
In response to recent developments in U.S. trade and tariff policy, we are pleased to offer the following formal clarification regarding the uninterrupted import, classification, and clinical use of Symbiopathic remedies within the United States.
✧ Ongoing Shipment and Fulfilment
All Symbiopathic homeopathic remedies—including both 5 ml and 10 ml presentations—continue to ship to the United States without interruption. Fulfilment and delivery timelines remain fully operational.
✧ Tariff Exemption Under USMCA
All of our remedies and their constituent components are entirely manufactured in Canada. As such, they remain fully compliant with Rules of Origin under the Canada–U.S.–Mexico Agreement (USMCA). This guarantees tariff-free movement into the United States and ensures seamless cross-border classification under relevant Harmonized Tariff Schedule (HTS) codes.
✧ NDC-Verified Classification for U.S. Import
Symbiopathic remedies are formally registered with the U.S. Food and Drug Administration (FDA) and are verified through National Drug Code (NDC) classification. Each remedy holds an NDC-compliant label, ensuring:
-
Recognition at the U.S. border as a legally permitted homeopathic drug under FDA guidelines
-
Consistency with all U.S. Customs and Border Protection (CBP) requirements for imported pharmaceutical-grade products
-
Absolute clarity in regulatory and clinical documentation, with traceability to FDA Homeopathic Drug Product Listings
This classification precludes arbitrary reclassification and protects against improper tariffs or seizures. Every shipment is supported by FDA registration records, NDC identifiers, and pre-cleared documentation protocols.
✧ No Pricing Adjustments or Surcharges
There have been no changes to pricing for U.S. customers. Your wholesale and clinical pricing remains stable. No additional surcharges, tariffs, or customs-based increases have been applied. Your ordering procedures and costs remain identical to pre-policy conditions.
✧ Regulatory Vigilance and Customs Oversight
We maintain direct oversight of all cross-border classification and documentation. This includes:
-
Active monitoring of FDA and CBP procedural changes
-
Real-time harmonisation of HTS, FDA, and NDC designations
-
Continuous updates to classification records and compliance materials to prevent disruption
In the unlikely event of a customs delay or misclassification, we will issue reimbursement.
✧ Clinical Stability and Institutional Confidence
We understand that clinical stability depends on regulatory clarity and logistical consistency. For decades, we have upheld the standards required to serve high-volume clinics, pharmacies, and physicians with rigorous expectations. That commitment remains absolute.
Should you require formal documentation—including NDC numbers, FDA listing details, or compliance statements for institutional review—please contact us directly.
It is our privilege to support the continuity of your clinical excellence.
In contemporary clinical practice, the integration of advanced and biologically attuned treatment modalities has become increasingly important. Symbiopathic remedies, grounded in the pioneering research of Dr. Günther Enderlein, offer a rigorously prepared, terrain-focused approach designed to support internal balance and biological regulation. Developed according to the principles of isopathy and homeopathy, these preparations provide a coherent framework for practitioners working within integrative and biological paradigms.
Symbiopathic remedies are precisely formulated homeopathic medicinal products that assist in modulating the internal milieu, fostering microbial symbiosis, and reinforcing the body's innate regulatory functions. Dr. Günther Enderlein, a distinguished German bacteriologist and immunologist, devoted his scientific career to exploring the dynamic interactions between microorganisms and human health. His foundational work continues to inform advanced biological and integrative medical models.
Our founder, a German-born expert trained in Switzerland, is one of only two individuals to have received direct instruction in Enderlein’s original methods from a senior protégé. He has preserved the fidelity of these preparations while guiding their ongoing refinement. Under his direction, Symbiopathic remedies continue to reflect the highest standards of the Enderlein tradition, combining historical precision with contemporary production technologies.
Through serial dilution and potentization, the bioactivity of each preparation is preserved and optimized while minimizing undesirable reactivity. Utilizing carefully selected fungal and bacterial strains, these remedies act upon foundational regulatory levels rather than targeting isolated symptoms. This systems-oriented approach considers the integrity of the internal environment as a whole.
Modern production methods ensure the exclusion of cell wall fragments, helping to minimize systemic burden while preserving the original terrain-regulating intent of the formulas. As such, Symbiopathic remedies are frequently incorporated into integrative clinical protocols that prioritize microbial balance, immune modulation, and long-term systemic support.
For practitioners, these remedies offer valuable tools in the management of complex and chronic presentations, especially within frameworks that address underlying dysregulation and terrain vulnerability. They may be integrated alongside conventional or complementary therapies to support the body’s broader biological coherence.
Symbiopathic – Biological Health Group Corp. represents a commitment to excellence in the field of homeopathic and biological medicine. With unwavering dedication to research integrity and pharmaceutical craftsmanship, Symbiopathic continues to support clinicians across the globe with high-quality formulations and consistent reliability. We are honored to serve those advancing integrative care in both established and emerging medical landscapes.
